Progressive Supranuclear PalsyNCT07844655
Wellness in PSP and CBD
A study testing Exercise and Peer Support in people with Progressive Supranuclear Palsy and Corticobasal Degeneration, run by Silke Cresswell at 1 site in Canada.
Trial summary
The goal of this interventional study is to evaluate the feasiblity and effectiveness of a multimodal lifestyle program for individuals living with Progressive Supranuclear Palsy or Corticobasal Deneration. The main objectivess of the study are to: 1. Assess the feasibility of the program 2. Read more about this study
- Who is it for?
- Ages 19 years and older
- Conditions the study is for
- Progressive Supranuclear Palsy, Corticobasal Degeneration
- What is being tested?
- Exercise and Peer Support
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- 1 siteCanada
- Study dates
- 10 Apr 2026to 31 Dec 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 19 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Age over 18 years.
- PSP or CBD diagnosis based on Movement Disorder Society criteria.
Who cannot join
- Significant cognitive impairment.
- Inability to fill in electronic questionnaires or understand study instructions.
- Any contraindication for exercise based on the Physical Activity Readiness for Everyone Questionnaire (PAR-Q+).
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Canada1 site, 1 recruiting
- Recruiting
Pacific Parkinson's Research Centre
Vancouver, British Columbia, V6E 4N2
Sahib Dhaliwal, 604-827-1353, sahib.dhaliwal@ubc.ca
About this study
Official title: Feasibility and Effectiveness of a Wellness Program in Individuals Living With Atypical Parkinsonism
The goal of this interventional study is to evaluate the feasiblity and effectiveness of a multimodal lifestyle program for individuals living with Progressive Supranuclear Palsy or Corticobasal Deneration. The main objectivess of the study are to:
- Assess the feasibility of the program
- Assess the effects of the program on emotional wellbeing and quality of life
- Assess the effects of the program on caregiver burden
Participants will join an 8-week program combining chair yoga, vocal strengthening, and peer support groups, conducted virtually. Participants will complete pre- and post- intervention questionnaires related to emotional wellbeing and quality of life. When applicable, care partners will be asked to complete a caregiver burden questionnaire.
- Being tested
- Exercise and Peer Support
- Keywords
- Atypical Parkinsonism, Taopathy, Progressive Supranuclear Palsy, Corticobasal Degeneration, Lifestyle Intervention
- Medical subject headings
- Supranuclear Palsy, Progressive, Corticobasal Degeneration
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Exercise and Peer SupportBehavioural
Chair yoga, and SongShine vocal strengthening, and. peer support groups,
| Study group | Role | What they receive |
|---|---|---|
| Intervention | Experimental | Not described Receives: Behavioral: Exercise and Peer Support |
What is being measured
The primary outcome is the main question the study is designed to answer.
Attendance and retention rates
Measured: From enrollment to completion of post- intervention questionnaires
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 Sep 2026
- Study start10 Apr 2026
- Primary completion31 Dec 2027 (estimated)
- Study completion31 Dec 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Progressive Supranuclear PalsyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Basic science
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 30 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Silke Cresswell
- Sponsor type
- University, hospital or other
- Collaborators
- University of California, San Diego, CurePSP, Parkinson Canada, Pacific Parkinson's Research Centre
- Responsible party
- Sponsor-investigator, Silke Cresswell, University of British Columbia
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07844655
- Sponsor's protocol ID
- H26-00263
- Status last verified
- Sep 2026
- First submitted
- 22 Sep 2026
- Last updated
- 28 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 28 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Feasibility and Effectiveness of a Wellness Program in Individuals Living With Atypical Parkinsonism
- ClinicalTrials.gov ID
- NCT07844655
- Acronym / sponsor ID
- H26-00263
- Keywords
- Atypical Parkinsonism, Taopathy, Progressive Supranuclear Palsy, Corticobasal Degeneration, Lifestyle Intervention
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 30 participants (estimated)
- Lead sponsor
- Silke CresswellUniversity, hospital or other
- Collaborators
- University of California, San Diego, CurePSP, Parkinson Canada, Pacific Parkinson's Research Centre
- Study start
- 10 Apr 2026 (actual)
- Primary completion
- 31 Dec 2027 (estimated)
- Study completion
- 31 Dec 2027 (estimated)
- First posted
- 28 Sep 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this interventional study is to evaluate the feasiblity and effectiveness of a multimodal lifestyle program for individuals living with Progressive Supranuclear Palsy or Corticobasal Deneration. The main objectivess of the study are to:
- Assess the feasibility of the program
- Assess the effects of the program on emotional wellbeing and quality of life
- Assess the effects of the program on caregiver burden
Participants will join an 8-week program combining chair yoga, vocal strengthening, and peer support groups, conducted virtually. Participants will complete pre- and post- intervention questionnaires related to emotional wellbeing and quality of life. When applicable, care partners will be asked to complete a caregiver burden questionnaire.
Study design
- Primary purpose
- Basic science
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Intervention | Experimental | Behavioral: Exercise and Peer Support |
Who may qualify
- Ages
- 19 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- Age over 18 years.
- PSP or CBD diagnosis based on Movement Disorder Society criteria.
Key exclusion criteria (3 listed)
- Significant cognitive impairment.
- Inability to fill in electronic questionnaires or understand study instructions.
- Any contraindication for exercise based on the Physical Activity Readiness for Everyone Questionnaire (PAR-Q+).
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Exercise and Peer SupportChair yoga, and SongShine vocal strengthening, and. peer support groups, | Behavioural | Intervention |
Primary outcome
Attendance and retention rates
Time frame: From enrollment to completion of post- intervention questionnaires
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Sep 2026.
- Individual participant dataSharing planned: No
Related trials for Progressive Supranuclear Palsy
RecruitingObservational study
Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Frontotemporal Dementia, Amyotrophic Lateral Sclerosis
RecruitingPhase 2
The Progressive Supranuclear Palsy Clinical Trial Platform
Progressive Supranuclear Palsy(PSP)
Recruiting
Transcranial Magnetic Stimulation in Progressive Supranuclear Palsy
Palsy Supranuclear, Supranuclear Palsy, Progressive
RecruitingPhase 3
A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy
Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS)
Not yet recruitingObservational study
Digital Health Technologies for Progressive Supranuclear Palsy and Dementia With Lewy Bodies
Progressive Supranuclear Palsy(PSP), Dementia With Lewy Bodies (DLB)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Exercise and Peer Support in people with Progressive Supranuclear Palsy and Corticobasal Degeneration, run by Silke Cresswell at 1 site in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 28 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Sahib Dhaliwal (604-827-1353, sahib.dhaliwal@ubc.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Attendance and retention rates (time frame: From enrollment to completion of post- intervention questionnaires). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Sep 2026.